The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 17, 2018
Filed:
Oct. 23, 2015
Applicant:
Bristol-myers Squibb Company, Princeton, NJ (US);
Inventors:
Scott Hunter Watterson, Pennington, NJ (US);
Andrew J. Tebben, New Hope, PA (US);
Saleem Ahmad, Wall, NJ (US);
Assignee:
Bristol-Myers Squibb Company, Princeton, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/403 (2006.01); A61K 31/4353 (2006.01); C07D 209/82 (2006.01); C07D 471/04 (2006.01); C07D 209/58 (2006.01); C07D 401/02 (2006.01); C07D 519/00 (2006.01); A61K 31/407 (2006.01); A61K 31/4035 (2006.01); A61K 31/437 (2006.01);
U.S. Cl.
CPC ...
C07D 209/58 (2013.01); A61K 31/407 (2013.01); A61K 31/4035 (2013.01); A61K 31/437 (2013.01); C07D 401/02 (2013.01); C07D 471/04 (2013.01); C07D 519/00 (2013.01);
Abstract
Disclosed are compounds of Formula (I): or a salt thereof, wherein Q is: or; and X, R, R, R, R, and Rare defined herein. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.